Blogging Journal Report Technical Review 
Xconomy
OCTOBER 7, 2016
military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology. —The U.S.
Xconomy
SEPTEMBER 2, 2016
As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson. He was a professor at UC San Diego.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
AUGUST 19, 2016
The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S. .
Xconomy
AUGUST 12, 2016
government’s Precision Medicine Initiative is an ambitious effort to collect the genomic data of 1 million Americans, and tech giant Alphabet (NASDAQ: GOOG ) is deeply involved. . —The U.S. Alex Lash examined the company’s role, via its biotech subsidiary Verily Life Sciences, in the massive project. —David H. In the U.S.,
SoCal Delicious
OCTOBER 8, 2012
Professor Journal. Student Journal. Loading… Tech. Developments Blog. SIGNIFICANCE PASSING-MENTION. --> Tech Titans Hit the Beach As Silicon Valley moguls go on a home-buying spree in Los Angeles, theyre reshaping the real-estate landscape. The tech industry is going south. MarketWatch. MarketWatch.
Xconomy
AUGUST 9, 2016
Apple’s iPhone 7 is due out next month. According to the Wall Street Journal, PFWTMs (“people familiar with the matter”) say the new device will look pretty much the same as the iPhone 6s. The biggest change: no more headphone plug. Doesn’t sound like much of an innovation. (Or I’ll come back to that below.)
Xconomy
AUGUST 5, 2016
The Wall Street Journal reported that Cambridge, MA-based Biogen (NASDAQ: BIIB ) has drawn interest from the likes of Merck (NYSE: MRK ) and Allergan (NYSE: AGN ) as a possible takeover target. Published in January, the technology comes from the lab of Keith Joung, who is an Editas cofounder. Bigelow contributed to this report.
Expert insights. Personalized for you.
77 
Let's personalize your content